18-49 years were 57% less likely (OR 0.43 95% CI 0.41-0.46, p < 0.0001), to receive antilipidemics than patients Ն65 years old. Patients with substantial disease burden (Charlson Index >1) were 9% more likely to receive antilipidemics (OR 1.09, 95% CI 1.01-1.18, p = 0.024) than those with no or moderate disease burden (Charlson Յ1). CONCLUSION: Although CHD remains a leading cause of U.S.mortality irrespective of sex, race/ethnicity, or age, and antilipidemics benefit patients across these demographic characteristics, we found that females, Blacks, and younger (aged 18-50 years) Medicaid patients with dyslipidemia were significantly less likely to receive antilipidemics than their male, White or older counterparts.
Witt JC, Webster E, Jensen PH University of Melbourne, Parkville, Victoria, Australia OBJECTIVES: The purpose of this study was to compare the survival of patients admitted to different types of hospitals for their first acute myocardial infarction (AMI), and to assess how the definition of failure and different variables affect the results.
METHODS:
The analysis utilized the Victorian Admitted Episodes Data Set from 1996-2005, which contains data on all patients admitted to acute private and public hospitals in the state of Victoria, Australia. A hazard model was used to model time to failure, which was defined either as 30-day mortality, or readmission for subsequent AMI. Hospitals were grouped into one of five types and these were included as explanatory variables. Other control variables, including AMI location, co-morbidities, treatments, and demographics, were added to the model one by one in order to determine their effect on survival, and on the effect of hospital type on survival. RESULTS: The impact and significance of hospital type on survival depended strongly on the definition of failure. Large teaching hospitals had significantly higher failure rates than all other hospital types when failure was defined as readmissions, while this ordering was almost reversed when failure was defined as 30-day mortality. Controlling for planned and unplanned treatments did not significantly affect these results. Including indices of socioeconomic status amplified the effects when failure was defined as readmissions, but had no significant effect otherwise. Location of AMI was significant only when failure was defined as 30-day mortality, and improved the relative performance of large regional base and suburban hospitals. All other variables were generally similar in both models. CONCLUSION: The effect of hospital type on survival depended strongly on the definition of failure and somewhat on the inclusion of certain control variables. The results suggest that comparing the effects of hospital type using patient outcomes requires careful consideration. (ESC 2003) . Descriptive statistics and comparison of averages ("t" of Student and Or of Mann-Whitney) and proportions (Chisquared) were realized with SAS package. RESULTS: A total of 1439 out of 1588 patients were valid for analysis (90.6%). A total of 80.3% were males, middle age were 62.4 yearsold (STD = 11.8) and the average BMI was of 27.8 Kg/m2 (STD = 3.7). The most frequent concomitant diseases were hypertension (53.6%) and diabetes mellitus type II (28.5%). The average of time after STEMI was 9.6 months (STD = 7.2). The treatments more frequently used were statins (93.6%), aspirin (93.2%) and beta-blockers (83.5%). The treatments used in accordance with guidelines were antiaggregants/anticoagulants (99.7% in both guidelines), statins (94.4% in ACC/AHA and 93.5% in ESC) and beta-blockers (83.5% in both guidelines), staying in the second term ACE inhibitors/ARBs (78.2% ACC/ AHA and 59.7% ESC) and aldosterone antagonists (19.3%), this one only recommended by the ACC/AHA. To summarize, 65.3% (ACC/AHA) and 52.4% (ESC) of the patients were being treated according guidelines. Regarding lifestyle factors, only 9.2% (ACC/AHA) and 6.4% of patients followed the overall guidelines' recommendations. CONCLUSION: This study shows a low implementation of guidelines by Spanish physicians in managing patients with STEMI, with more adherences to ACC/AHA 2004 than ESC 2003 guidelines. Treatment recommendations are more followed than life-style recommendations. Based on this study, actions are needed to increase adherence of Guidelines in Spain.
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